The Valley Desk

Clinical trial reportBlood neoplasiaPublished

A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Coriell Institute for Medical Research, Fox Chase Cancer Center, Temple University, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Blood neoplasia
Published
PubMed ID
40453133
PubMed Central ID
PMC12067906
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal